Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
Covid-19
Long-COVID
Motor symptoms
Non-motor symptoms
Parkinson's disease
Parkinsonism
SARS-CoV-2
Journal
International review of neurobiology
ISSN: 2162-5514
Titre abrégé: Int Rev Neurobiol
Pays: United States
ID NLM: 0374740
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
8
10
2022
pubmed:
9
10
2022
medline:
12
10
2022
Statut:
ppublish
Résumé
The Coronavirus Disease 2019 (Covid-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has led to unprecedented challenges for the delivery of healthcare and has had a clear impact on people with chronic neurological conditions such as Parkinson's disease (PD). Acute worsening of motor and non-motor symptoms and long-term sequalae have been described during and after SARS-CoV-2 infections in people with Parkinson's (PwP), which are likely to be multifactorial in their origin. On the one hand, it is likely that worsening of symptoms has been related to the viral infection itself, whereas social restrictions imposed over the course of the Covid-19 pandemic might also have had such an effect. Twenty cases of post-Covid-19 para-infectious or post-infectious parkinsonism have been described so far where a variety of pathophysiological mechanisms seem to be involved; however, a Covid-19-induced wave of post-viral parkinsonism seems rather unlikely at the moment. Here, we describe the interaction between SARS-CoV-2 and PD in the short- and long-term and summarize the clinical features of post-Covid-19 cases of parkinsonism observed so far.
Identifiants
pubmed: 36208907
pii: S0074-7742(22)00033-2
doi: 10.1016/bs.irn.2022.04.004
pmc: PMC9357514
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
63-89Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
World J Clin Cases. 2021 Feb 16;9(5):1058-1078
pubmed: 33644169
J Neurol Sci. 2021 Mar 15;422:117331
pubmed: 33540185
Front Comput Neurosci. 2013 Mar 18;7:13
pubmed: 23515615
Patient Prefer Adherence. 2015 Jul 10;9:989-98
pubmed: 26203231
J Neurol Sci. 2020 Nov 15;418:117090
pubmed: 32805440
Parkinsonism Relat Disord. 2020 Nov;80:7-9
pubmed: 32920322
BMJ Case Rep. 2021 Mar 2;14(3):
pubmed: 33653852
Am J Emerg Med. 2021 Sep;47:333.e1-333.e3
pubmed: 33712341
Lancet Neurol. 2020 Oct;19(10):804-805
pubmed: 32949534
Neuropsychopharmacology. 2001 Apr;24(4):410-9
pubmed: 11182536
Arch Med Res. 2020 Oct;51(7):739-740
pubmed: 32571606
Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G508-14
pubmed: 14563668
Front Neuroendocrinol. 2012 Aug;33(3):315-27
pubmed: 23000204
Parkinsonism Relat Disord. 2020 Jun;75:126-127
pubmed: 32414669
Eur J Neurol. 2021 Oct;28(10):3491-3502
pubmed: 33982853
Mediators Inflamm. 2015;2015:792578
pubmed: 25873770
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1107-11
pubmed: 21478206
PLoS One. 2014 Jun 02;9(6):e94944
pubmed: 24887491
J Parkinsons Dis. 2021;11(2):431-444
pubmed: 33492244
Biochim Biophys Acta. 2009 Jul;1792(7):714-21
pubmed: 18760350
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):515-545
pubmed: 35142947
Mov Disord. 2020 Jun;35(6):905-908
pubmed: 32347572
Adv Protein Chem Struct Biol. 2012;88:69-132
pubmed: 22814707
Neuropsychopharmacology. 2013 Oct;38(11):2179-87
pubmed: 23657438
Brain. 2017 Aug 1;140(8):2246-2251
pubmed: 28899018
Clin Park Relat Disord. 2021;5:100116
pubmed: 34786554
J Parkinsons Dis. 2020;10(4):1365-1377
pubmed: 32925107
Int Rev Neurobiol. 2020;152:131-156
pubmed: 32450994
J Parkinsons Dis. 2020;10(4):1343-1353
pubmed: 32986683
J Infect Dis. 2021 Jan 4;223(1):28-37
pubmed: 32986824
Mov Disord. 2021 Jul;36(7):1483-1484
pubmed: 34043246
J Neurol. 2021 Nov;268(11):3980-3987
pubmed: 33884450
Neurologia. 2022 Oct;37(8):706-708
pubmed: 34785833
Mov Disord. 2012 Jan;27(1):156-7
pubmed: 21989835
Nat Rev Neurol. 2020 Aug;16(8):403
pubmed: 32591754
BMC Neurol. 2021 Aug 30;21(1):332
pubmed: 34461838
Parkinsonism Relat Disord. 2010 Nov;16(9):566-71
pubmed: 20650672
IDCases. 2022;27:e01388
pubmed: 35018281
Clin Neuropharmacol. 2007 Mar-Apr;30(2):101-6
pubmed: 17414942
J Neurol. 2021 Apr;268(4):1179-1187
pubmed: 32880722
Mov Disord. 2020 May;35(5):716-720
pubmed: 32291797
Neurology. 2020 Oct 13;95(15):e2109-e2118
pubmed: 32641525
J Med Virol. 2020 Oct;92(10):1743-1744
pubmed: 32246784
Lancet Neurol. 2021 Feb;20(2):94-95
pubmed: 33253627
J Infect. 2009 May;58(5):321-8
pubmed: 19368974
Parkinsonism Relat Disord. 2013 Aug;19(8):709-16
pubmed: 23660544
J Neurovirol. 2021 Oct;27(5):667-690
pubmed: 34581996
Mov Disord. 2020 Aug;35(8):1293-1294
pubmed: 32519352
J Neurol Sci. 2021 Feb 15;421:117316
pubmed: 33561753
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
Eur J Neurol. 2013 Aug;20(8):1113-20
pubmed: 23433314
Clin Case Rep. 2021 Jul 06;9(7):e04409
pubmed: 34257979
J Investig Med. 2022 Mar;70(3):766-772
pubmed: 35058334
Trends Neurosci. 2020 Dec;43(12):931-933
pubmed: 33158605
J Neurol. 2022 Jan;269(1):59-61
pubmed: 34216264
J Mov Disord. 2022 Jan;15(1):89-92
pubmed: 34781632
J Neurol Sci. 2022 Feb 15;433:120014
pubmed: 34629181
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S233-6
pubmed: 20082998
NPJ Parkinsons Dis. 2015 Aug 27;1:15014
pubmed: 28725683
BMC Res Notes. 2017 Nov 29;10(1):655
pubmed: 29187231
Mov Disord. 2020 Aug;35(8):1287-1292
pubmed: 32449528
Mov Disord. 2021 Jun;36(6):1287-1289
pubmed: 33890344
JAMA Neurol. 2014 May;71(5):589-595
pubmed: 24687146
J Neural Transm (Vienna). 2017 Aug;124(8):901-905
pubmed: 28150045
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Psychoneuroendocrinology. 2015 Feb;52:302-10
pubmed: 25554999
Signal Transduct Target Ther. 2021 Nov 23;6(1):406
pubmed: 34815399
Parkinsonism Relat Disord. 2013 Aug;19(8):737-41
pubmed: 23680419
Trends Neurosci. 2007 May;30(5):244-50
pubmed: 17418429
Mov Disord. 2020 Oct;35(10):1712-1716
pubmed: 32776601
Life Sci. 2007 Apr 3;80(17):1564-71
pubmed: 17307202
Mov Disord. 2020 Oct;35(10):1721-1722
pubmed: 32815213
Eur J Neurol. 2021 Oct;28(10):3348-3359
pubmed: 33682276
J Nucl Med. 2021 Aug 1;62(8):1171-1176
pubmed: 34016729